Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes
by University of California - San DiegoIn a patient-derived tumor model in mice, glioblastoma tumors (dark purple) shrink significantly when treated with both the MS drug teriflunomide and the ta
Updated on: May 05,2024
12

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes
by University of California - San DiegoIn a patient-derived tumor model in mice, glioblastoma tumors (dark purple) shrink significantly when treated with both the MS drug teriflunomide and the ta
Updated on:May 05,2024
12
